Vartmarbuda ↔ Eyelid Malignancy (Basal Cell, Squamous Cell, Sebaceous Gland Carcinoma, Melanoma)

Vartmarbuda is built, per the source material, as this unit's deliberate capstone on lid malignancy, consolidating red flags scattered across six earlier lessons into one framework. The classical term names a growth only in the most generic sense, and while individual warning signs (recurrence, non-healing, bleeding) surface throughout this unit's classical teaching, the systematic eight-feature red-flag framework, the four-malignancy differential, and margin-controlled surgical treatment are modern additions with no classical correlate.

IN PLAIN LANGUAGE

Some eyelid lumps are cancer rather than a harmless cyst or chalazion. Basal cell carcinoma is the most common and rarely spreads; sebaceous gland carcinoma is especially dangerous because it can look exactly like an ordinary chalazion that keeps coming back; squamous cell carcinoma and melanoma are rarer at this site but more aggressive.

Classical Chedana (surgical excision) is the same broad surgical tool used definitively in modern treatment, but the classical framework has no method of its own to recognise which lesions actually need biopsy first, no way to tell the different cancer types apart, and no equivalent of margin-controlled surgery. This is one area where local or classical treatment must never delay a modern diagnosis.

WHEN TO SEEK CARE

See an eye doctor if any eyelid lesion grows unusually fast, doesn't heal, bleeds easily, causes lash loss at that spot, has an irregular or unevenly coloured border, feels fixed to the tissue underneath, keeps coming back despite treatment, or occurs in an older person — any one of these means the lesion should be biopsied before any other treatment is tried.

🔴 REFER IMMEDIATELY

Rapid growth faster than expected for the presumed benign diagnosis
Non-healing or ulceration beyond the expected timeframe
Bleeding with only minor trauma
Madarosis (lash loss) at the lesion site
Irregular pigmentation or border
Fixation to underlying tissue
Recurrence at the same site despite apparently adequate treatment of a presumed benign diagnosis
Occurrence in an older patient, especially with a sun exposure history
Any single one of the eight red-flag features, present on any lid lesion whatever it superficially resembles
Confirmed or strongly suspected lid malignancy of any type

Never do this

Do not apply Lekhana, Kshara, or any other local classical measure to a lid lesion with any red-flag feature, and do not delay definitive surgical referral to trial a period of local or symptomatic treatment first — this is a genuine and avoidable clinical error, not a reasonable conservative first step.

🟢 SUITABLE FOR ROUTINE / COLLABORATIVE CARE

AYURVEDA SCOPE

None specific to malignancy itself; the classical framework offers no diagnostic method to identify or stage a lid malignancy, and its surgical tool (Chedana) is appropriate only once a modern diagnosis and biopsy have established what is actually being excised and with what margin.

MODERN MEDICINE SCOPE

Recognition of the eight-feature red-flag framework; biopsy before treatment; margin-controlled excision (Mohs micrographic surgery for high-risk basal cell/squamous cell carcinoma); lid reconstruction; specific vigilance for sebaceous gland carcinoma masquerading as recurrent chalazion.

COLLABORATIVE SCOPE

A practitioner from either tradition who first sees a red-flag lid lesion must route the patient to biopsy and modern oncologic management rather than trial any local or classical treatment first; classical local measures have no role once malignancy is confirmed or strongly suspected.

Sign in to read the full comparison

The plain-language summary and safety guidance above are free for everyone. The 10-dimension scholarly comparison needs an account.